Received Apr 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | JT347 | — |
Underage administration (2 month old patient); This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number JT347, expiry date 30-SEP-2025) for prophylaxis. On 19-MAR-2025, the patient received Menveo. On 19-MAR-2025, an unknown time after receiving Menveo, the patient experienced inappropriate age at vaccine administration (Verbatim: Underage administration (2 month old patient)). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 07-APR-2025 The other health professional reported that since in the audit just found a male two month old patient was administered a Menveo 1 vial vaccine which led to inappropriate age at vaccine administration.